; (B) submitted to the Racing Medication and Testing Consortium, the Harness Racing Medication Collaborative, and the American Quarter Horse Association Medication Committee; and (C) provided to any individual or entity requesting such information. (3) Recording of input If any input from a covered person (or a representative of a covered person) is provided during a meeting referred to in paragraph (1), or provided in writing, such input shall be transcribed and recorded and made part of the record of the scientific medication control committee concerned. (4) Review of medication and threshold rules (A) In general Each scientific medication control committee shall review— (i) all existing medication and threshold rules issued by State racing commissions with respect to covered horses; and (ii) all available research on medication thresholds for covered horses. (B) Penalty recommendations A scientific medication control committee may revise penalty recommendations with respect to each substance reviewed as part of the medication and threshold review under subparagraph (A). (C) Medications Each scientific medication control committee shall— (i) review the development of any new medication on an ongoing basis to determine whether such medication should be subject to the medication control rules issued pursuant to section 101(c); and (ii) if the scientific medication control committee determines that such a medication should be subject to such rules, the scientific medication control committee shall develop and submit to the Board for approval proposed modifications to such rules to include such medication. 202. Horseracing scientific medication control rules (a) Applicability Scientific medication control rules issued under section 101(c)(1) for each breed of covered horse shall apply to— (1) covered horseraces, covered persons, and covered horses in member States